Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 4.5 - 11 mm: medical device reports filed with FDA

4,547 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

4,547
device reports naming the brand
0% of all MAUDE reports · about 642 a year
539
reports, 12 months to August 2026
682 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,547 reports that name the brand "OsseoSpeed TX 4.5 - 11 mm" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

539 reports arrived in the 12 months to August 2026, down 21% from 682 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (34.1%), loss of osseointegration (32.2%) and failure to osseointegrate (28.2%). The patient problems coded most often are failure of implant, inflammation and osteolysis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

081162Sep 2021: 32Oct 2021: 42Nov 2021: 41Dec 2021: 472022Jan 2022: 57Feb 2022: 43Mar 2022: 62Apr 2022: 65May 2022: 40Jun 2022: 36Jul 2022: 41Aug 2022: 61Sep 2022: 40Oct 2022: 53Nov 2022: 57Dec 2022: 382023Jan 2023: 53Feb 2023: 37Mar 2023: 39Apr 2023: 39May 2023: 52Jun 2023: 56Jul 2023: 88Aug 2023: 162Sep 2023: 46Oct 2023: 55Nov 2023: 67Dec 2023: 412024Jan 2024: 66Feb 2024: 70Mar 2024: 53Apr 2024: 62May 2024: 56Jun 2024: 68Jul 2024: 79Aug 2024: 100Sep 2024: 55Oct 2024: 61Nov 2024: 47Dec 2024: 412025Jan 2025: 68Feb 2025: 33Mar 2025: 83Apr 2025: 30May 2025: 29Jun 2025: 60Jul 2025: 97Aug 2025: 78Sep 2025: 72Oct 2025: 30Nov 2025: 39Dec 2025: 332026Jan 2026: 61Feb 2026: 23Mar 2026: 54Apr 2026: 45May 2026: 32Jun 2026: 42Jul 2026: 84Aug 2026: 24

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

06491,2982019: 14620192021: 1,29820212022: 59320222023: 73520232024: 75820242025: 65220252026: 3652026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,545
Malfunction0%2
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%4,547
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem1,54934.1%7.7%
Loss of osseointegration1,46332.2%22.4%
Failure to osseointegrate1,28028.2%62.8%
Fracturea broken bone2756%1.6%
Crackthe device cracked130.3%0%
Loosening of implant not related to bone-ingrowth130.3%0.1%
Malposition of device80.2%0.1%
Damaged thread10%0%
Device dislodged or dislocated10%0%
Improper or incorrect procedure or method10%0%
Insufficient device problem information10%0.2%
Migration or expulsion of device10%0%
Off-label use10%0%
Patient-device incompatibilitythe device did not suit the patient10%0%
Positioning problem10%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant4,54099.8%
Inflammationinflammation62913.8%
Osteolysis2906.4%
Pocket erosion2836.2%
Implant pain110.2%
Fistula30.1%
Sinus perforation30.1%
Erosion20%
Hypersensitivity/allergic reaction20%
Numbnessnumbness20%
Abscessa collection of pus10%
Cyst(s)10%
Hypoesthesia10%
Inadequate osseointegration10%
Infiltration into tissue10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 4.5 - 11 mmProduct code DZEAll MAUDE reports
Reports4,5473,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 4.5 - 11 mm reports

How many FDA reports name OsseoSpeed TX 4.5 - 11 mm?

4,547 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 539 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (34.1%), loss of osseointegration (32.2%), failure to osseointegrate (28.2%), fracture (6%) and crack (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 4.5 - 11 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.